{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:39:46Z","timestamp":1778747986449,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013640","name":"Deutsche Morgenl\u00e4ndische Gesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013640","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.nmd.2025.105368","type":"journal-article","created":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T07:37:01Z","timestamp":1747553821000},"page":"105368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["278th ENMC International Workshop: European standards for harmonization of myasthenia gravis registries and emerging digital solutions. 20th-21st September 2024, Hoofddorp, The Netherlands"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0246-1455","authenticated-orcid":false,"given":"Sabrina","family":"Sacconi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiammetta","family":"Vanoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frauke","family":"Stascheit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Cort\u00e9s-Vicente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato","family":"Mantegazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Meisel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Meisel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernestina","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Verschuuren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils Erik","family":"Gilhus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Lafor\u00eat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter-Bram","family":"Hoen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Sacconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adela Della","family":"Marina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Antozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena Cortes","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuelle Salort","family":"Campana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiammenta","family":"Vanoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frauke","family":"Stascheit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Ashragi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato","family":"Mantegazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanislav","family":"Vohanka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Brauner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terenshina","family":"Evangelista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederico","family":"Spandonaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Hoffmeister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Gary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip","family":"Callawaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JT","family":"Tibung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludgarde","family":"Allard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthieu","family":"Lusignan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raqual","family":"Pardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2025.105368_bib0001","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in Myasthenia Gravis","volume":"10","author":"Carr","year":"2010","journal-title":"BMC Neurol"},{"key":"10.1016\/j.nmd.2025.105368_bib0002","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1196\/annals.1254.053","article-title":"The epidemiology of myasthenia gravis","volume":"998","author":"Phillips","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.nmd.2025.105368_bib0003","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis","volume":"5","author":"Gilhus","year":"2019","journal-title":"Nat Rev Dis Primer"},{"key":"10.1016\/j.nmd.2025.105368_bib0004","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2025.105368_bib0005","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.3390\/jcm11061597","article-title":"Current treatment of Myasthenia Gravis","volume":"11","author":"Alhaidar","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.nmd.2025.105368_bib0006","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis: executive summary","volume":"87","author":"Sanders","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2025.105368_bib0007","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100066","article-title":"Terminal complement inhibitor Ravulizumab in generalized Myasthenia Gravis","volume":"1","author":"Vu","year":"2022","journal-title":"NEJM Evid"},{"key":"10.1016\/j.nmd.2025.105368_bib0008","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S1474-4422(21)00159-9","article-title":"Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial","volume":"20","author":"Howard","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2025.105368_bib0009","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1474-4422(24)00498-8","article-title":"Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study","volume":"24","author":"Antozzi","year":"2025","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2025.105368_bib0010","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41582-023-00916-w","article-title":"Myasthenia gravis: the changing treatment landscape in the era of molecular therapies","volume":"20","author":"Iorio","year":"2024","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.nmd.2025.105368_bib0011","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0140-6736(10)60680-0","article-title":"The case for a global rare-diseases registry","volume":"377","author":"Forrest","year":"2011","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.nmd.2025.105368_bib0012","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13023-024-03520-3","article-title":"Toward European harmonization of national myasthenia gravis registries: modified Delphi procedure-based expert consensus on collectable data","volume":"20","author":"Slioui","year":"2025","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2025.105368_bib0013","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1055\/s-0041-1724104","article-title":"Recent trends in patient registries for health services research","volume":"60","author":"Stausberg","year":"2021","journal-title":"Methods Inf Med"},{"key":"10.1016\/j.nmd.2025.105368_bib0014","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/ane.12021","article-title":"The origin of registry-based medical research and care","author":"Irgens","year":"2012","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1016\/j.nmd.2025.105368_bib0015","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1749-6632.2012.06771.x","article-title":"Patient registries: useful tools for clinical research in myasthenia gravis","volume":"1274","author":"Baggi","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.nmd.2025.105368_bib0016","unstructured":"ERDRI.dor 2025 https:\/\/eu-rd-platform.jrc.ec.europa.eu\/erdridor\/ (accessed March 4, 2025)."},{"key":"10.1016\/j.nmd.2025.105368_bib0017","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40290-020-00332-1","article-title":"Establishing patient registries for rare diseases: rationale and challenges","volume":"34","author":"Boulanger","year":"2020","journal-title":"Pharm Med"},{"key":"10.1016\/j.nmd.2025.105368_bib0018","series-title":"Registries for evaluating patient outcomes: A user\u2019s guide","author":"Gliklich","year":"2010"},{"key":"10.1016\/j.nmd.2025.105368_bib0019","unstructured":"Guideline on registry-based studies - scientific guideline | European Medicines Agency (EMA) 2021. https:\/\/www.ema.europa.eu\/en\/guideline-registry-based-studies-scientific-guideline (accessed December 11, 2024)."},{"key":"10.1016\/j.nmd.2025.105368_bib0020","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/ene.12703","article-title":"Myasthenia gravis: descriptive analysis of life-threatening events in a recent nationwide registry","volume":"22","author":"Ramos-Fransi","year":"2015","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2025.105368_bib0021","doi-asserted-by":"crossref","first-page":"e1171","DOI":"10.1212\/WNL.0000000000008903","article-title":"Clinical and therapeutic features of myasthenia gravis in adults based on age at onset","volume":"94","author":"Cort\u00e9s-Vicente","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2025.105368_bib0022","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1111\/ene.14820","article-title":"Clinical characteristics and outcomes of thymoma-associated myasthenia gravis","volume":"28","author":"\u00c1lvarez-Velasco","year":"2021","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2025.105368_bib0023","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/acn3.51492","article-title":"Drug-refractory myasthenia gravis: clinical characteristics, treatments, and outcome","volume":"9","author":"Cort\u00e9s-Vicente","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.nmd.2025.105368_bib0024","unstructured":"Myasthenie Register. Dtsch Myasthenie Ges EV n.d. https:\/\/dmg.online\/myasthenie-register\/ (accessed March 4, 2025)."},{"key":"10.1016\/j.nmd.2025.105368_bib0025","unstructured":"Leiden L.A. 2 2333 Z. Nederlands-Belgisch Myasthenie Register. myasthenie\u00ebn 2018. https:\/\/mgexpertisecentrum.nl\/research\/nederlands-belgisch-myasthenie-register\/ (accessed March 4, 2025)."},{"key":"10.1016\/j.nmd.2025.105368_bib0026","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/joim.12310","article-title":"The autoimmune spectrum of myasthenia gravis: a Swedish population-based study","volume":"277","author":"Fang","year":"2015","journal-title":"J Intern Med"},{"key":"10.1016\/j.nmd.2025.105368_bib0027","unstructured":"Swedish Neuromuscular Association. Myastenia Gravis (MG), Svenskt konsensusprogram 2024:23."},{"key":"10.1016\/j.nmd.2025.105368_bib0028","unstructured":"Registr MyReg: \u00davod 2025 https:\/\/myreg.registry.cz\/index.php (accessed March 4, 2025)."},{"key":"10.1016\/j.nmd.2025.105368_bib0029","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/jnnp-2022-329169","article-title":"Mortality and cause of death in multiple sclerosis in western Norway 1950-2021: a registry-based linkage study","volume":"93","author":"Willumsen","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2025.105368_bib0030","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1468-1331.2010.03089.x","article-title":"Myasthenia gravis requiring pyridostigmine treatment in a national population cohort","volume":"17","author":"Andersen","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2025.105368_bib0031","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16233","article-title":"The epidemiology and societal costs of myasthenia gravis in Norway: a non-interventional study using national registry data","volume":"31","author":"Engebretsen","year":"2024","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2025.105368_bib0032","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/ane.12233","article-title":"Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries","author":"Andersen","year":"2014","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1016\/j.nmd.2025.105368_bib0033","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/mus.25068","article-title":"Epidemiology of myasthenia gravis in Northern Portugal: frequency estimates and clinical epidemiological distribution of cases","volume":"54","author":"Santos","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2025.105368_bib0034","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0960-8966(98)00077-7","article-title":"Juvenile myasthenia gravis with prepubertal onset","volume":"8","author":"Evoli","year":"1998","journal-title":"Neuromuscul Disord NMD"},{"key":"10.1016\/j.nmd.2025.105368_bib0035","doi-asserted-by":"crossref","first-page":"e939","DOI":"10.1542\/peds.2013-0814","article-title":"Clinical characteristics of pediatric myasthenia: a surveillance study","volume":"132","author":"VanderPluym","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.nmd.2025.105368_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.834212","article-title":"The epidemiology and phenotypes of ocular manifestations in childhood and juvenile myasthenia gravis: a review","volume":"13","author":"Heckmann","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.nmd.2025.105368_bib0037","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pediatrneurol.2012.07.008","article-title":"Management of juvenile myasthenia gravis","volume":"48","author":"Ionita","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.nmd.2025.105368_bib0038","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.nmd.2021.02.003","article-title":"Corrigendum to \u201cworkshop report: 242nd ENMC international workshop: diagnosis and management of juvenile myasthenia gravis, Hoofddorp, The Netherlands, 1-3 March 2019\u201d [Neuromuscular Disorders 30 (2020) 254-264]","volume":"31","author":"Munot","year":"2021","journal-title":"Neuromuscul Disord NMD"},{"key":"10.1016\/j.nmd.2025.105368_bib0039","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.pediatrneurol.2024.04.020","article-title":"Eculizumab in adolescent patients with refractory generalized Myasthenia Gravis: a phase 3, open-label, multicenter study","volume":"156","author":"Brandsema","year":"2024","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.nmd.2025.105368_bib0040","doi-asserted-by":"crossref","DOI":"10.1177\/22143602241296314","article-title":"The telemedical platform MyaLink for remote monitoring in myasthenia gravis - rationale and protocol for a proof of concept study","author":"Stein","year":"2024","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2025.105368_bib0041","doi-asserted-by":"crossref","DOI":"10.2196\/58266","article-title":"App- and wearable-based remote monitoring for patients with Myasthenia Gravis and its specialists: feasibility and usability study","volume":"9","author":"Stein","year":"2025","journal-title":"JMIR Form Res"},{"key":"10.1016\/j.nmd.2025.105368_bib0042","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-068104","article-title":"Patient-reported impact of myasthenia gravis in the real world: findings from a digital observational survey-based study (MyRealWorld MG)","volume":"13","author":"Berrih-Aknin","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.nmd.2025.105368_bib0043","doi-asserted-by":"crossref","unstructured":"Berling E., Orlikowski D., Nicolas G., Prigent H., N\u2019Dah Sekou G., Carment L., et al. 2025 ME&MG, novel digital device for patients with generalized Myasthenia gravis: a first step towards validation (P1-11.016) 04092024;102.","DOI":"10.1212\/WNL.0000000000204973"},{"key":"10.1016\/j.nmd.2025.105368_bib0044","unstructured":"The ME&MG Digital Solution for autonomous assessment of Myasthenia Gravis. CtvVeevaCom 2025 https:\/\/ctv.veeva.com\/study\/the-me-mg-digital-solution-for-autonomous-assessment-of-myasthenia-gravis (accessed March 12, 2025)."},{"key":"10.1016\/j.nmd.2025.105368_bib0045","unstructured":"Descriptive analysis of real-world data collected with ME&MGopen 2025 https:\/\/inclinicaltrials.com\/myasthenia-gravis\/NCT05566964\/ (accessed March 12, 2025)."},{"key":"10.1016\/j.nmd.2025.105368_bib0046","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13023-024-03059-3","article-title":"EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders","volume":"19","author":"Atalaia","year":"2024","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2025.105368_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e16367","article-title":"Real world study on prevalence, treatment and economic burden of myasthenia gravis in Italy","volume":"9","author":"Antonini","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.nmd.2025.105368_bib0048","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1186\/s13023-022-02558-5","article-title":"Towards FAIRification of sensitive and fragmented rare disease patient data: challenges and solutions in European reference network registries","volume":"17","author":"Dos Santos Vieira","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2025.105368_bib0049","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1186\/s13023-021-02004-y","article-title":"The de novo FAIRification process of a registry for vascular anomalies","volume":"16","author":"Groenen","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2025.105368_bib0050","doi-asserted-by":"crossref","DOI":"10.3389\/fdgth.2023.1203945","article-title":"Current challenges and potential solutions to the use of digital health technologies in evidence generation: a narrative review","volume":"5","author":"Mumtaz","year":"2023","journal-title":"Front Digit Health"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896625000951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896625000951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:08:40Z","timestamp":1762344520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896625000951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":50,"alternative-id":["S0960896625000951"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2025.105368","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"278th ENMC International Workshop: European standards for harmonization of myasthenia gravis registries and emerging digital solutions. 20th-21st September 2024, Hoofddorp, The Netherlands","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2025.105368","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105368"}}